close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

225.18 +2.19 (+0.98%)
Official Closing Price Updated: 7:00 PM EST, Dec 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,744,324
Open 225.00
Bid (Size) 224.32 (100)
Ask (Size) 226.10 (600)
Prev. Close 222.99
Today's Range 221.00 - 225.98
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 2.91%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Guardian Wealth Doubles Down on LKQ Stock With $1.8 Million Purchase, According to Recent SEC Filing ↗
Guardian Wealth Management raised its stake in LKQ stock to nearly $4.9 Million during the third quarter of 2025. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Guardian Wealth Takes $5.1 Million Stake in Viper Energy, According to Recent SEC Filing ↗
Guardian Wealth bought over 133,000 shares of Viper Energy during the third quarter of 2025. 
Via The Motley Fool
Topics Energy Regulatory Compliance

Performance

YTD
+25.5%
+25.5%
1 Month
+3.0%
+3.0%
3 Month
+6.4%
+6.4%
6 Month
+17.6%
+17.6%
1 Year
+28.2%
+28.2%

More News

Read More
News headline image
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
1 Major Factor Behind the Healthcare Sector's Recent Surge ↗
Via The Motley Fool
News headline image
3 Top Dividend Stocks to Buy in December ↗
Via The Motley Fool
Topics Initial Public Offering Intellectual Property
News headline image
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. ↗
Via The Motley Fool
Topics ETFs
News headline image
Could Buying AbbVie Today Set You Up for Life? ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit
News headline image
3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
Morgan Stanley Downgrades Regeneron (REGN) to Equal-Weight, Citing Fair Valuation and Pipeline Scrutiny
Via MarketMinute
Topics Intellectual Property
News headline image
2 Top Dividend Stocks to Buy Now and Hold For a Decade ↗
Via The Motley Fool
Topics Artificial Intelligence Cannabis Intellectual Property
News headline image
3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years ↗
Via The Motley Fool
Topics Stocks
News headline image
8 Dividend Stocks Every Investor Should Consider ↗
Via The Motley Fool
News headline image
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗
Via Stocktwits
Topics ETFs
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
1 Surging Stock with Exciting Potential and 2 Facing Challenges
Via StockStory
Topics Bankruptcy
News headline image
5 Dividend Stocks to Hold for the Next 10 Years ↗
Via The Motley Fool
Topics Energy Retirement
News headline image
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
Via StockStory
Topics Economy Government World Trade
News headline image
Unpacking the Latest Options Trading Trends in AbbVie ↗
Via Benzinga
News headline image
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today ↗
Via Benzinga
News headline image
HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗
Via MarketBeat
News headline image
Healthcare Rotation Underway: 3 Stocks Leading the Charge ↗
Via MarketBeat
News headline image
3 Cash-Producing Stocks We Think Twice About
Via StockStory
Topics Derivatives
News headline image
A Look Into AbbVie Inc's Price Over Earnings ↗
Via Benzinga
News headline image
AbbVie Stock Falls 4% -- What Investors Need to Know ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? ↗
Via The Motley Fool
Topics ETFs Government World Trade

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 225.18
When was AbbVie last traded?
The last trade of AbbVie was at 12/10/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today